CUSIP: 78470E205
Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / MSCI EMR MKT ETF
-
Total 13F shares
-
386,561
-
Share change
-
+2,871
-
Total reported value
-
$25,519,107
-
Price per share
-
$66.02
-
Number of holders
-
23
-
Value change
-
+$201,547
-
Number of buys
-
13
-
Number of sells
-
8
Security key
78470E205
Report period
Q3 2020
Institutions
23
Top holders
10
Reporting periods
Holder history for CUSIP 78470E205
Recent filing periods:
Top shareholders of EEMX - SPDR INDEX SHS FDS - MSCI EMR MKT ETF (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of SPDR INDEX SHS FDS - MSCI EMR MKT ETF (EEMX) as of Q3 2020
As of 30 Sep 2020,
SPDR INDEX SHS FDS - MSCI EMR MKT ETF (EEMX) was held by
23 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
386,561 shares.
The largest 10 holders included
LAKE STREET ADVISORS GROUP, LLC, Fulcrum Capital LLC, JANE STREET GROUP, LLC, PARTNERS CAPITAL INVESTMENT GROUP, LLP, BINGHAM OSBORN & SCARBOROUGH LLC, LPL Financial LLC, CITADEL ADVISORS LLC, Angeles Investment Advisors, LLC, Miracle Mile Advisors, LLC, and BAILARD, INC..
This page lists
23
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
Compare Q3 2020 vs Q2 2020 Across Filers
| Investor |
Q2 2020 Shares |
Q3 2020 Shares |
Share Diff |
Share Chg % |
Q2 2020 Value $ |
Q3 2020 Value $ |
Value Diff $ |
Value Chg % |
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.